Arterial hypertension in renal transplant recipients treated with tacrolimus or cyclosporine-neoral

被引：7
|
作者：
Nichelle, L [1 ]
Canet, S [1 ]
Garrigue, V [1 ]
Chong, G [1 ]
Mourad, G [1 ]
机构：
[1] Univ Hosp Lapeyronie, Dept Nephrol & Transplantat, Montpellier, France
来源：
TRANSPLANTATION PROCEEDINGS | 2002年 / 34卷 / 07期
关键词：
D O I：
10.1016/S0041-1345(02)03530-3
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2824 / 2825
页数：2
相关论文
共 50 条
  • [41] Successful reconversion from tacrolimus to cyclosporine A neoral in pediatric liver recipients
    Melter, M
    Rodeck, B
    Kardorff, R
    Hoyer, PF
    Maibucher, A
    Brodehl, J
    [J]. TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2276 - 2278
  • [42] Cyclosporine pharmacokinetics in renal allograft recipients with diabetes mellitus treated with sandimmune and sandimmune neoral
    Serafinowicz, A
    Gaciong, Z
    Baczkowska, T
    Durlik, M
    Lao, M
    [J]. TRANSPLANTATION PROCEEDINGS, 1996, 28 (06) : 3140 - 3141
  • [43] Diltiazem use in tacrolimus-treated renal transplant recipients
    Kothari, J
    Nash, M
    Zaltzman, J
    Prasad, GVR
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2004, 29 (05) : 425 - 430
  • [44] Subclinical rejection in tacrolimus-treated renal transplant recipients
    Gloor, JM
    Cohen, AJ
    Lager, DJ
    Grande, JP
    Fidler, ME
    Velosa, JA
    Larson, TS
    Schwab, TR
    Griffin, MD
    Prieto, M
    Nyberg, SL
    Sterioff, S
    Kremers, WK
    Stegall, MD
    [J]. TRANSPLANTATION, 2002, 73 (12) : 1965 - 1968
  • [45] CYCLOSPORINE-A AND HYPERTENSION IN PEDIATRIC RENAL-TRANSPLANT RECIPIENTS
    OGBORN, MR
    CROCKER, JFS
    BELITSKY, P
    MACDONALD, AS
    BITTERSUERMANN, H
    DIGOUT, SC
    [J]. TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 1705 - 1706
  • [46] Conversion from tacrolimus to Neoral in liver and kidney transplant recipients
    Ott, R
    Bussenius-Kammerer, M
    Scholz, D
    Neuhaus, R
    Tolba, RH
    Fricke, L
    Müller, V
    [J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3166 - 3168
  • [47] Tacrolimus (FK506) versus cyclosporine microemulsion (Neoral) as maintenance immunosuppression therapy in kidney transplant recipients
    Abou-Jaoude, MM
    Najm, R
    Shaheen, J
    Nawfal, N
    Abboud, S
    AlHabash, M
    Darwish, M
    Mulhem, A
    Ojjeh, A
    Almawi, WY
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (07) : 3025 - 3028
  • [48] PROGRESSION OF FIBROSIS IN HCV plus LIVER TRANSPLANT RECIPIENTS TREATED WITH CYCLOSPORINE OR TACROLIMUS
    Nevens, Frederik
    Klintmalm, Goran
    Villamil, Federico G.
    Jones, Robert
    Clavien, Pierre-Alain
    Metselaar, Herold J.
    Prestele, Hans
    Orsenigo, Roberto
    Levy, Gary
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 146 - 146
  • [49] Comparison of the cardiovascular risk profile in renal transplant recipients treated with tacrolimus or cyclosporine based immunosuppressive regimen.
    Citterio, F
    Rossi, E
    Tondolo, V
    Romagnoli, J
    Castagneto, M
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 243 - 243
  • [50] IN VIVO CYP3A-ACTIVITY IS SIGNIFICANTLY LOWER IN CYCLOSPORINE THAN IN TACROLIMUS TREATED RENAL TRANSPLANT RECIPIENTS
    de Jonge, H.
    de Loor, H.
    Verbeke, K.
    Vanrenterghem, Y.
    Kuypers, D. R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S44 - S44
12345